Cathepsins are protease enzymes that can be divided into several families. Cathepsins come in serine, cysteine, or aspartyl protease varieties. Humans have cathepsins from about 15 different classes (Cathepsin A, B, C, D, E, F, G, H, K, L, O, S, V, W, and Z). Cathepsins perform a variety of tasks and are active in the lysosome's low pH environment. Similar to other enzymes, they are essential for a variety of physiological processes, including apoptosis, vesicular trafficking, autophagy, angiogenesis, proliferation, metastasis, digestion, blood clotting, bone resorption, ion channel activity, innate immunity, complement activation, and a host of others.
Numerous pathologies, such as arthritis, periodontitis, pancreatitis, macular degeneration, muscular dystrophy, atherosclerosis, obesity, stroke, Alzheimer's disease, schizophrenia, tuberculosis, and Ebola, have been linked to the dysregulated cathepsins.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
V28590 | 3-Epiursolic Acid | 989-30-0 | 3-Epiursolic Acid is a triterpenoid that can be extracted from Eriobotrya japonica. | |
V87355 | Arg-Arg-AMC acetate | Arg-Arg-AMC acetate is the acetate form of Arg-Arg-AMC. | ||
V87360 | Bz-FVR-AMC TFA | Bz-FVR-AMC TFA is a fluorescent substrate for cathepsin with a kcat/Km value of 1070 mM-1s-1. High concentrations of BZ-FVR-AMC have an inhibitory effect on the substrate. | ||
V78655 | Cathepsin C-IN-6 | Cathepsin C-IN-6 (compound 2) is an E-64c-hydrazine-based cathepsin C (cathepsin C) inhibitor (antagonist) with anti-inflammatory activity. | ||
V77164 | Cathepsin D and E FRET Substrate acetate | Cathepsin D and E FRET Substrate acetate is a fluorogenic substrate for cathepsin D and E, not for B, H or I, and its cleavage occurs at the Phe-Phe amide bond. | ||
V78656 | Cathepsin D/E Substrate, Fluorogenic | Cathepsin D/E Substrate, Fluorogenic, an 11-amino acid (AA) peptide, is a selective substrate for cathepsins D and E. | ||
V85302 | Cathepsin G | 107200-92-0 | ||
V83635 | Cathepsin H, human liver | 60748-73-4 | ||
V78657 | Cathepsin Inhibitor 3 | 3026372-49-3 | Cathepsin Inhibitor 3 (Compound 53k) is a non-radioactive intermediate in the radiosynthesis of compound [18F]2k and is selective for cathepsin S. | |
V87359 | Cathepsin Inhibitor 4 | Cathepsin Inhibitor 4 (Compound 45) is a selective inhibitor of Cathepsin S with Ki of 0.04 nM. | ||
V77985 | Cathepsin K inhibitor 4 | Cathepsin K inhibitor 4 is a potent carbohydrazide cathepsin K inhibitor, with IC50s of 13 nM, 269 nM, and 296 nM for human, rat, and mouse cathepsin K respectively. | ||
V101025 | Cathepsin K inhibitor 7 | Cathepsin K inhibitor 7 (Compound 7) is a Cathepsin K inhibitor with a pKi value of 7.3 for CatK. | ||
V86253 | Cathepsin L-IN-3 | 478164-48-6 | ||
V85549 | Cathepsin L-IN-4 (1-Naphthalenesulfonyl-Ile-Trp-CHO) | 161709-56-4 | ||
V78658 | Cathepsin L/S-IN-1 | Cathepsin L/S-IN-1 is a dual (bifunctional) inhibitor of Cathepsin L and Cathepsin S with IC50 of 4.10 μM and 1.79 μM respectively. | ||
V93268 | CTSC-IN-1 | CTSC-IN-1 (B22) is a CTSC inhibitor. | ||
V87358 | CTSL/CAPN1-IN-1 | CTSL/CAPN1-IN-1 (compound 14a) is an orally active CTSL and CAPN1 inhibitor with IC50 values of 3.34 nM and 375.1 nM, respectively. | ||
V87357 | CTSL/CAPN1-IN-2 | 2410075-64-6 | CTSL/CAPN1-IN-2 (Compound 14b) is an orally active CTSL and CAPN1 inhibitor with IC50 values of 6.88 nM and 347.6 nM, respectively. | |
V88344 | Dutacatib | 501000-36-8 | Dutacatib is an inhibitor of SARS-CoV-2 3CLpro and cathepsin K, has antiviral activity, and can improve cancer-induced bone disease. | |
V3413 | E-64 HCl | E-64 HCl, the hydrochloride salt form of E-64, which isisolated from cultures of Aspergillus, is anovel, potent,irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain. |